Rxcurve
HCPCS J9227 · per 10 MG

Inj. isatuximab-irfc 10 mg

Products billed under this code include Sarclisa.

Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9227

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Sarclisa Sanofi-Aventis U.S. LLC 00024-0654-01 10 $898.12
Sarclisa Sanofi-Aventis U.S. LLC 00024-0656-01 50 $4,490.60

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $89.812 +$1.652 10 MG Inj. isatuximab-irfc 10 mg v1, posted September 17, 2026
3Q26 $88.16 +$4.583 10 MG Inj. isatuximab-irfc 10 mg v1, posted September 15, 2026
2Q26 $83.577 −$0.718 10 MG Inj. isatuximab-irfc 10 mg v1, posted September 15, 2026
1Q26 $84.295 +$2.395 10 MG Inj. isatuximab-irfc 10 mg v1, posted September 15, 2026
4Q25 $81.90 −$0.96 10 MG Inj. isatuximab-irfc 10 mg v1, posted September 8, 2026
3Q25 $82.86 +$4.005 10 MG Inj. isatuximab-irfc 10 mg v1, posted March 10, 2026
2Q25 $78.855 −$0.492 10 MG Inj. isatuximab-irfc 10 mg v1, posted March 10, 2026
1Q25 $79.347 +$1.298 10 MG Inj. isatuximab-irfc 10 mg v1, posted December 19, 2025
4Q24 $78.049 +$0.057 10 MG Inj. isatuximab-irfc 10 mg v1, posted June 11, 2025
3Q24 $77.992 +$1.572 10 MG Inj. isatuximab-irfc 10 mg v1, posted June 11, 2025
2Q24 $76.42 −$0.077 10 MG Inj. isatuximab-irfc 10 mg v1, posted March 11, 2025
1Q24 $76.497 +$1.856 10 MG Inj. isatuximab-irfc 10 mg v1, posted December 19, 2024
4Q23 $74.641 +$0.292 10 MG Inj. isatuximab-irfc 10 mg v1, posted October 10, 2024
3Q23 $74.349 +$2.652 10 MG Inj. isatuximab-irfc 10 mg v1, posted June 5, 2024
2Q23 $71.697 −$0.251 10 MG Inj. isatuximab-irfc 10 mg v1, posted February 23, 2024
1Q23 $71.948 +$1.503 10 MG Inj. isatuximab-irfc 10 mg v1, posted December 6, 2023
4Q22 $70.445 −$0.051 10 MG Inj. isatuximab-irfc 10 mg v1, posted June 22, 2023
3Q22 $70.496 +$1.62 10 MG Inj. isatuximab-irfc 10 mg v1, posted June 9, 2023
2Q22 $68.876 −$0.148 10 MG Inj. isatuximab-irfc 10 mg v1, posted December 14, 2022
1Q22 $69.024 +$1.426 10 MG Inj. isatuximab-irfc 10 mg v1, posted June 8, 2022
4Q21 $67.598 −$0.10 10 MG Inj. isatuximab-irfc 10 mg v1, posted June 2, 2022
3Q21 $67.698 +$1.477 10 MG Inj. isatuximab-irfc 10 mg v1, posted June 2, 2022
2Q21 $66.221 −$0.151 10 MG Inj. isatuximab-irfc 10 mg v1, posted March 1, 2022
1Q21 $66.372 – 10 MG Inj. isatuximab-irfc 10 mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files